Regulatory
Regulation of Homeopathic Medicines in Canada
Submitted by David Skinner, Canadian Homeopathic Pharmaceutical Association Homeopathic medicines (HMs) are regulated in Canada by Health Canada, the federal government department responsible for ensuring the safety, efficacy, and…
Read MoreRegulatory Status of Homeopathy in the EU & UK: What’s Happened Since Brexit?
By Steve Mann, Director of External Regulatory Affairs, Nelsons To say the world has changed over the last couple of years might just be the understatement of the century…
Read MoreA Global Perspective on Effectiveness Standards for Homeopathic Medicinal Products: Is there a “Third Way”?
By Robbert van Haselen, Chair, HPCUS Clinical Documentation Committee; Director, World Integrated Medicine Forum We currently live in an increasingly polarized world, and this is also reflected in the…
Read MoreBe ’Recall Ready’: FDA Wants to Help You Fulfill Your Regulatory Requirements
By Eric Foxman, AAHP Secretary Does your company market or distribute an FDA-regulated product? If so, then FDA has a document for you. FDA wants all manufacturers and downstream distribution…
Read MoreMeet the Incumbent FDA Commissioner, Robert Califf, MD
Prominent cardiologist Robert Califf, MD, will once again serve as FDA Commissioner after being confirmed by the Senate on Feb. 15. Dr. Califf was first nominated to the position by…
Read MoreNew FDA Documents on Cough/Cold Products and Annual Reporting
The Food and Drug Administration recently released two documents of interest to manufacturers and distributors of homeopathic drugs. The first is a “consumer update” concerning the use of cough/cold products…
Read MoreGOP Buoyed by Election Outcome; Democrats View Economic Plan as Difference Maker in 2022
By Pete Evich, AAHP Lobbyist and Vice President at Van Scoyoc Associates Republicans touted their electoral gains across the country on Tuesday, Nov. 2, believing that voters may be…
Read MoreFDA’s Growing Expertise in Homeopathic Manufacturing
By George Bernstein, PhD If you have participated in AAHP Summits over the past couple of years, you are no doubt aware that FDA has raised the bar regarding…
Read MoreAn In-Depth Review of AAHP’s 2021 Summit
By Eric L. Foxman, Pharmacist, AAHP Secretary Having listened to the speakers at AAHP’s 2021 Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2, I came away with several thoughts…
Read MoreSuccess: Implementing HPUS Guidelines for FDA Compliance, Part 2
By Mark Land, AAHP President Co-hosted by AAHP and HPCUS on June 15, the Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2 was an overwhelming success from multiple perspectives.…
Read More